Harlan Waksal
Chairman chez LYRA THERAPEUTICS, INC.
Fortune : 3 M $ au 31/03/2024
Profil
Dr. Harlan W.
Waksal, MD, is an Executive Chairman at Lyra Therapeutics, Inc. and a President, Chief Executive Officer & Director at Kadmon Corp.
LLC.
He is on the Board of Directors at Kadmon Corp.
LLC and Montclair Art Museum.
Dr. Waksal was previously employed as a President & Director by Kadmon Holdings, Inc., a Chairman by Sevion Therapeutics, Inc., a President by Waksal Consulting LLC, a Chairman-New Jersey Region by American Committee for the Weizmann Institute of Science, a Chief Executive Officer by Kadmon Holdings, Inc., and a Trustee by Oberlin College.
He also served on the board at NeuroBioPharm, Inc., Neptune Technologies & Bioresources, Inc., Acasti Pharma, Inc. and ImClone Systems, Inc. He received his undergraduate degree from Oberlin College and a doctorate degree from Tufts University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LYRA THERAPEUTICS, INC.
0,90% | 18/03/2024 | 536 966 ( 0,90% ) | 3 M $ | 31/03/2024 |
Postes actifs de Harlan Waksal
| Sociétés | Poste | Début |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Chairman | 16/02/2022 |
Montclair Art Museum
 Montclair Art Museum Other Consumer ServicesConsumer Services Montclair Art Museum is an institution that showcases a significant collection of George Inness' artworks, as well as other exhibitions such as Woolpunk®: Sunflowers & Graffiti'd Sky in the Garden State, Transformed: Objects Reimagined by American Artists, and New Acquisitions: Jeremy Dennis. The non-profit company is based in Montclair, NJ. The museum also offers family programs and membership opportunities. | Director/Board Member | - |
Kadmon Corp. LLC
 Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Chief Executive Officer | 24/09/2014 |
Anciens postes connus de Harlan Waksal
| Sociétés | Poste | Fin |
|---|---|---|
| KADMON HOLDINGS, INC. | Chief Executive Officer | 09/11/2021 |
Sevion Therapeutics, Inc.
 Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | Chairman | 04/03/2016 |
| Oberlin College | Director/Board Member | 01/01/2016 |
| ACASTI PHARMA INC. | Chief Tech/Sci/R&D Officer | 01/10/2014 |
| NEPTUNE WELLNESS SOLUTIONS INC. | Director/Board Member | 14/07/2015 |
Formation de Harlan Waksal
| Oberlin College | Undergraduate Degree |
| Tufts University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NEPTUNE WELLNESS SOLUTIONS INC. | Health Technology |
| ACASTI PHARMA INC. | Health Technology |
| LYRA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | Commercial Services |
Kadmon Holdings, Inc.
 Kadmon Holdings, Inc. BiotechnologyHealth Technology Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics to address unmet medical need. The company's clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies. The firms late-stage product candidate KD025, which is an orally administered selective inhibitor of Rho-associated coiled-coil kinase engages in development for the treatment of inflammatory and fibrotic diseases. The firm's a pivotal clinical trial of KD025 is underway in chronic graft-versus-host disease (cGVHD), as well as a Phase 2 clinical trial in systemic sclerosis. It is also developing next-generation immuno-oncology therapies, specifically IL-15 containing fusion proteins, for the treatment of cancer. The company's lead I-O product candidate, KD033, is an anti-PD-L1/IL-15 fusion protein. Kadmon was founded by Steven N. Gordon in September 2010 and is headquartered in New York, NY. | Health Technology |
Montclair Art Museum
Montclair Art Museum Other Consumer ServicesConsumer Services Montclair Art Museum is an institution that showcases a significant collection of George Inness' artworks, as well as other exhibitions such as Woolpunk®: Sunflowers & Graffiti'd Sky in the Garden State, Transformed: Objects Reimagined by American Artists, and New Acquisitions: Jeremy Dennis. The non-profit company is based in Montclair, NJ. The museum also offers family programs and membership opportunities. | Consumer Services |
| Waksal Consulting LLC | |
American Committee for the Weizmann Institute of Science
 American Committee for the Weizmann Institute of Science Miscellaneous Commercial ServicesCommercial Services American Committee for the Weizmann Institute of Science operates as a community of visionary people who advance the partnership between science and philanthropy. It partners with individuals, families, foundations, and the business community to develop philanthropic funding for the institute; educates the American public about the institute’s research; and represents the institute’s interests in the U.S. through the events such as galas, parlor meetings, and luncheons; meetings with institute scientists and campaigns to spread the news of research discovery. The company was founded by Chaim Weizmann in November 1944 and is headquartered in New York, NY. | Commercial Services |
NeuroBioPharm, Inc.
 NeuroBioPharm, Inc. Pharmaceuticals: MajorHealth Technology Part of Neptune Wellness Solutions, Inc., NeuroBioPharm, Inc. is a Canadian company that engages in the research and development of novel proprietary active pharmaceutical ingredients for cognitive and neurological conditions. The private company is based in Laval, Canada. NeuroBioPharm was acquired by Neptune Wellness Solutions, Inc. on February 20, 2015 for $0.22 million. | Health Technology |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Health Technology |
